RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law
• Scheduled for standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System.
Locations
United States
Alabama
University of Alabama at Birmingham
COMPLETED
Birmingham
Idaho
St. Lukes Idaho Cardiology Associates
COMPLETED
Boise
Massachusetts
Lahey Clinic, Inc.
COMPLETED
Burlington
New Hampshire
Catholic Medical Center
RECRUITING
Manchester
New Jersey
Valley Hospital
COMPLETED
Ridgewood
Other Locations
Italy
Fondazione Centro San Raffaele
COMPLETED
Milan
Monaco
Centre Hospitalier Princesse Grace
RECRUITING
Monaco
Contact Information
Primary
Sharda Mehta
sharda.mehta@bsci.com
Backup
Sharon Mensah
Sharon.Mensah@bsci.com
Time Frame
Start Date: 2016-05
Estimated Completion Date: 2025-12
Participants
Target number of participants: 100
Treatments
All Subjects
All subjects are included in this cohort and are treated with the Rhythmia Mapping System
Authors
Thomas H McElderry, Marcos Daccarett, Paolo Della Bella
Related Therapeutic Areas
Sponsors
Leads: Boston Scientific Corporation